TrialTranslational vision science & technology2022

Exploratory Phase II Multicenter, Open-Label, Clinical Trial of ST266, a Novel Secretome for Treatment of Persistent Corneal Epithelial Defects.

Bennie H Jeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.